Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPH
50.09 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 137.545 | 91.386 | 63.301 | 1.097 | 46.505 | -6.66 | 4.508 | 10.532 | -2.787 | -10.699 | 11.862 | 18.094 | 7.752 |
| Depreciation & Amortization
| 41.777 | 28.741 | 26.752 | 25.18 | 21.121 | 16.516 | 15.436 | 14.564 | 13.252 | 14.448 | 13.078 | 11.497 | 11.15 |
| Deferred Income Tax
| -12.578 | -15.751 | 4.209 | 1.123 | 7.552 | -1.878 | 3.933 | -3.271 | -7.881 | -8.244 | 2.081 | 8.275 | -36.006 |
| Stock Based Compensation
| 20.242 | 17.86 | 18.687 | 20.498 | 17.295 | 16.68 | 17.087 | 15.124 | 12.815 | 9.28 | 7.035 | 7.425 | 8.04 |
| Change In Working Capital
| -24.209 | -32.177 | -1.924 | 9.128 | -51.747 | 12.104 | 0.582 | 0.297 | -5.138 | 15.619 | -3.231 | -49.646 | 27.579 |
| Accounts Receivables
| -26.086 | -10.132 | -14.921 | -20.16 | 6.702 | -16.295 | -8.102 | 6.377 | -11.012 | 1.21 | 11.824 | -16.647 | -1.171 |
| Inventory
| -1.724 | -11.746 | 1.258 | 15.297 | -41.103 | -5.984 | 18.65 | -9.715 | 9.775 | 6.565 | -18.538 | -25.219 | -1.901 |
| Accounts Payables
| 13.237 | -0.736 | 3.016 | 14.963 | -17.937 | 29.159 | 6.687 | -0.823 | -3.131 | 5.5 | 4.203 | -8.008 | 20.814 |
| Other Working Capital
| -9.636 | -9.563 | 8.723 | -0.972 | 0.591 | 5.224 | -16.653 | 4.458 | -0.77 | 2.344 | -0.72 | 0.228 | 9.837 |
| Other Non Cash Items
| 20.726 | -0.878 | -13.031 | 0.24 | 1.036 | 1.429 | -2.337 | 1.314 | 0.42 | 0.648 | 0.217 | 2.705 | 0.581 |
| Operating Cash Flow
| 183.503 | 89.181 | 97.994 | 57.266 | 41.762 | 38.191 | 39.209 | 38.56 | 10.681 | 21.052 | 31.042 | -1.65 | 19.096 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -38.166 | -24.034 | -27.456 | -33.855 | -41.555 | -46.808 | -35.099 | -21.382 | -16.047 | -20.499 | -18.302 | -25.245 | -10.718 |
| Acquisitions Net
| -506.406 | 0.421 | 0 | 0 | 0 | 4.645 | 2 | -12.461 | 0.051 | -18.352 | 0 | 0 | 0 |
| Purchases Of Investments
| -144.556 | -35.761 | -17.375 | -13.557 | -8.815 | -0.308 | -5.645 | -3.602 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 38.622 | 27.969 | 18.771 | 12.411 | 0 | 0.091 | 3.65 | 3.075 | 0 | 0 | 0.513 | 0.81 | 0.185 |
| Other Investing Activites
| 1.39 | -1.372 | -2.612 | -1.414 | -0.157 | 0.198 | -3.661 | -5.131 | -0.878 | -0.922 | -0.509 | -0.677 | -0.002 |
| Investing Cash Flow
| -649.116 | -32.777 | -28.672 | -36.415 | -50.527 | -42.182 | -38.755 | -39.501 | -16.925 | -39.773 | -18.298 | -25.112 | -10.535 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -501.263 | -1.781 | -37.901 | -8.401 | -6.781 | -5.705 | -9.712 | -4.454 | -2.206 | -54.214 | -73.152 | -30.126 | -5.9 |
| Common Stock Issued
| 10.974 | 15.658 | 15.925 | 23.165 | 18.298 | 38.036 | 13.758 | 21.502 | 14.822 | 38.018 | 0 | 0 | 0 |
| Common Stock Repurchased
| -58.144 | -39.909 | -28.873 | -24.425 | -22.291 | -25.047 | -30.747 | -9.908 | -9.865 | -0.734 | -0.199 | -0.811 | -1.754 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -25.079 | 15.251 | 29.756 | 30.58 | 6.991 | 38.036 | 18.983 | 21.502 | 14.308 | 101.123 | 63.981 | 54.174 | -0.922 |
| Financing Cash Flow
| 454.093 | -26.439 | -37.018 | -2.246 | -3.783 | 25.008 | -7.718 | 7.14 | 2.237 | 32.117 | -9.37 | 23.237 | -8.576 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| -0.282 | -0.22 | -0.223 | 0.352 | -0.104 | -0.274 | 0.504 | 0.081 | 2.253 | 0.845 | 0 | 0 | 0 |
| Net Change In Cash
| -11.802 | 29.745 | 32.081 | 18.957 | -12.652 | 20.743 | -6.76 | 6.28 | -1.754 | 14.241 | 3.374 | -3.525 | -0.015 |
| Cash At End Of Period
| 144.531 | 156.333 | 126.588 | 94.507 | 75.55 | 88.202 | 65.594 | 72.354 | 66.074 | 67.828 | 53.587 | 50.213 | 53.738 |